Biotech VC's
What are some biotech focused vc's that invest in first in class early stage oncology assets and not some risk averse medtech bshit?
Trending Content
Career Resources
WSO Free Modeling Series - Now Open Through
April 30, 2024
9 Free Financial Modeling Lessons
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
+Bonus: Get 27 financial modeling templates in swipe file
+Bonus: Get 27 financial modeling templates in swipe file
Based on the most helpful WSO content, some top-tier early-stage biotech venture capital firms that are known for leading Series A deals and might be interested in first-in-class early stage oncology assets include:
These firms are akin to the MBB (McKinsey, Bain, BCG) or bulge bracket banks of the biotech VC world, often leading the pack in terms of investment in innovative and groundbreaking biotech startups. They are known for their deep scientific expertise and may be more inclined to invest in cutting-edge oncology research rather than more conservative medtech ventures.
Sources: Healthcare / Biotech Venture Capital?, Biotech finance: from IB to VC / HF to funded startup, Guide To Evaluate a Biotech Company, Guide To Evaluate a Biotech Company
In the US or in Europe?
London
Nextech Invest
Northpond Ventures
5AM Ventures
Ascension Ventures
Yosemite
Unde ut eos ut in iure. Tempore eveniet et porro quibusdam deserunt eius voluptatem.
Quia facere est minus repellat. Aut enim est consequatur aut quidem eveniet. Qui maxime iure dolor dicta quia impedit esse.
Vero qui saepe molestiae quam voluptas. Ut aspernatur hic nam neque nemo voluptatem. Ratione perspiciatis voluptatem beatae facere.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...